Category: Finance
Meeka’s 1.2Moz Murchison gold project could get even bigger with 2km anomaly at the Bunarra Shear Zone
Mapping and surface sampling at Bunarra highlights a +2km shear zone at Meeka’s Murchison project Work suggests en echelon splays within the sheared central mafic [more…]
Stamp duty now costs your average Sydney homebuyer half a year’s income
Silent but deadly, stamp duty costs in this country are about as funny as a fart in an elevator. Now Aussie home buyers have to [more…]
Ground Breakers: US15 million bucks for a ‘world class’ asset? Only in coal
South32 will receive an initial payment of just US$15 million ($23m) for its 50% share in the Eagle Downs met coal project in Queensland’s Bowen [more…]
Exceptional performance of Arizona Lithium’s DLE pilot plant is a positive sign for Prairie’s future operations
Arizona Lithium’s DLE pilot plant produces very high quality and consistent results Plant delivers +13,500L of high-purity lithium concentrate Operational data will be used to [more…]
Visible gold puts a spring in M2M’s step on the journey to a maiden resource at Golden Crown
Shallow RC drilling at M2M’s Golden Crown prospect returns visible gold in 10 intervals Assays pending for drilling, which will be used to calculate a [more…]
Here’s why Australian Mines answered the clarion call from its Brazilian critical minerals projects
New Brazilian critical minerals projects have plenty of potential to deliver Tier 1 discoveries for the soon-to-be-rebranded Australian Mines Jequie is next to the 510Mt [more…]
Drill results at Aspacia have revealed its potential to become Brightstar Resources’ next golden ticket
6,000m of RC drilling has returned shallow gold hits of up to 18.88g/t Results confirm >600m of strike along the historically mined underground mine Maiden [more…]
Top 10 at 11: Assay results and juicy defence contract are making news today.
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning [more…]
ASX Health Stocks: CSL’s Phase 3 AEGIS-II trial disappoints, fails to meet primary efficacy endpoint
CSL’s Phase 3 AEGIS-II trial did not meet primary efficacy endpoint Argenica Therapeutics all set to commence Phase 2 trial Cleo Diagnostics to move CXCL10 [more…]
First concentrate at Kanmantoo: Hillgrove Resources a minted copper producer once again
First copper produced from revived Kanmantoo mine in South Australia Production and output to increase over the coming months 65% reduction in electricity costs [more…]
